Nasdaq - Delayed Quote USD

Fidelity Select Pharmaceuticals Port (FPHAX)

26.42 +0.02 (+0.08%)
At close: 8:01 PM EDT
Loading Chart for FPHAX
DELL
  • Previous Close 26.40
  • YTD Return 18.51%
  • Expense Ratio 0.76%
  • Category Health
  • Last Cap Gain 35.00
  • Morningstar Rating
  • Morningstar Risk Rating Average
  • Sustainability Rating
  • Net Assets 1.32B
  • Beta (5Y Monthly) 0.58
  • Yield 0.50%
  • 5y Average Return --
  • Holdings Turnover 44.00%
  • Last Dividend 0.05
  • Inception Date Jun 18, 2001

The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.

Fidelity Investments

Fund Family

Health

Fund Category

1.32B

Net Assets

2001-06-18

Inception Date

Performance Overview: FPHAX

Trailing returns as of 4/25/2024. Category is Health.

YTD Return

FPHAX
18.51%
Category
7.95%
 

1-Year Return

FPHAX
33.76%
Category
30.16%
 

3-Year Return

FPHAX
14.34%
Category
16.10%
 

5-Year Return

FPHAX
14.68%
Category
15.71%
 

People Also Watch

Holdings: FPHAX

Top 10 Holdings (70.92% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 23.81%
NVO
Novo Nordisk A/S 14.41%
AZN
AstraZeneca PLC 8.23%
GSK
GSK plc 4.87%
MRK
Merck & Co., Inc. 4.80%
UCB.BR
UCB SA 3.87%
RPRX
Royalty Pharma plc 3.13%
GILD
Gilead Sciences, Inc. 3.02%
MRNA
Moderna, Inc. 2.55%
LEGN
Legend Biotech Corporation 2.23%

Sector Weightings

SectorFPHAX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Related Mutual Fund News

Top Mutual Funds